Invasive mammary carcinomas with different progesterone receptor isoform ratios: metastatic vs. proliferative ability, which is worse?
ANDROGEN RECEPTORS AND WNT PATHWAY AS THERAPEUTIC TARGETS IN ENDOCRINE RESISTANT BREAST CANCER MODELS
Combination of GnRH Agonist/Antagonist with Protein Kinase Inhibitors Counteracts Growth and Metastasis in Breast Cancer
Seeking the Truth Behind the Myth: Nuclear Role for Argonaute-1 as an Estrogen-Dependent Enhancer Coactivator
Metronomic chemotherapy combining paclitaxel and a muscarinic agonist for triple negative breast cancer treatment
Recovery of specific miRNAs in heparinized plasma obtained from HER2+ breast cancer patients who underwent neoadjuvant therapy protocol.
